CervoMed Inc. (NASDAQ:CRVO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sol J. Barer Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jan 1, 2018); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); Aevi Genomic Medicine LLC (Director · Jun 30, 2012 – Feb 3, 2020 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · May 1, 2011 – Nov 29, 2016 · Past); Amicus Therapeutics Inc (Director · Jan 6, 2009 – Jun 9, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past) | Director · Nov 1, 2013 – Jul 24, 2014 · Past |
| Isaac Blech Other companies: X4 Pharmaceuticals, Inc. (Director · Mar 13, 2019 – Mar 13, 2019 · Past); Aridis Pharmaceuticals Inc. (Director · Aug 13, 2018 – Aug 13, 2018 · Past); InspireMD Inc. (Director · Jan 22, 2016 – Dec 7, 2016 · Past); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Dec 31, 2018 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); SpendSmart Networks Inc (Director · Aug 1, 2014 – Jul 19, 2016 · Past); Aevi Genomic Medicine LLC (Director · Nov 11, 2013 – Apr 15, 2016 · Past) | Director · Jul 24, 2014 – Aug 31, 2016 · Past |
| Eric Francois Other companies: 60 Degrees Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); CERo Therapeutics Holdings, Inc. (Director · Since at least Feb 13, 2026); Scynexis, Inc. (Chief Financial Officer · Nov 1, 2015 – Jan 29, 2021 · Past) | Director · Jun 25, 2021 – Jul 1, 2021 · Past |
| Stephen M. Simes Other companies: CytoDyn Inc. (Director · Since at least Oct 13, 2022); ANI Pharmaceuticals, Inc. (Vice Chairman, President & CEO, Director · Dec 14, 2007 – Jan 25, 2012 · Past) | Chief Executive Officer, Director · Mar 5, 2014 – Jul 24, 2014 · Past |
| Matthew Winton Other companies: Inozyme Pharma Inc (COO · Since at least Mar 13, 2024) | Chief Commercial and Business Officer · Since at least Oct 6, 2025 |
| Rex Bright Other companies: VYNE Therapeutics Inc. (Director · Jul 19, 2021 – Jul 19, 2021 · Past) | Director · Feb 5, 2014 – Jul 24, 2014 · Past |
| William Karl Hornung Other companies: Hepion Pharmaceuticals, Inc. (Chief Financial Officer · Jun 23, 2014 – Jun 4, 2015 · Past) | Chief Financial Officer · Sep 21, 2018 – Jan 27, 2022 · Past |
| Christopher D Galloway | Chief Medical Officer · Oct 19, 2020 – Jan 27, 2022 · Past |
| Craig Abolin | VP of Research & Dev - Subsid. · Nov 18, 2013 – Jun 3, 2014 · Past |
| David Quigley | Senior Partner · Since at least Oct 28, 2025 |
| Diana M Lanchoney | Director · Jun 25, 2021 – Jun 30, 2023 · Past |
| Frank Zavrl | Director · Since at least Nov 5, 2026 |
| Jane H. Hollingsworth | Director · Since at least Nov 5, 2026 |
| Jeff Poulton | Director · Since at least Nov 4, 2026 |
| Jill Davidson | Director · Jul 26, 2023 – Sep 15, 2023 · Past |
| John Alam | Co-Founder and Chief Executive Officer · Since at least Jun 23, 2025 |
| John William Tanner | Chief Financial Officer · Aug 16, 2023 – Jan 26, 2024 · Past |
| Joshua Boger | Chair Of The Board · Since at least Jun 10, 2026 |
| Kelly Blackburn | Executive Vice President, Clinical Development · Since at least Mar 12, 2026 |
| Marco Verwijs | Executive Vice President, Technical Operations · Since at least Mar 4, 2026 |
| Mark A Weinberg | Sr.V.P.- Clinical Development · Aug 4, 2014 – Aug 4, 2014 · Past |
| Mark De Rosch | Executive Vice President, Regulatory and Government Affairs, and Program Management · Since at least May 1, 2025 |
| Mark T Giles | Director · Jan 8, 2016 – Jul 1, 2021 · Past |
| Marwan Sabbagh | Director · Since at least Aug 16, 2023 |
| Nelson K Stacks | Director · Nov 18, 2013 – Jul 24, 2014 · Past |
| PJ Kelleher | Investor Relations · Since at least Dec 4, 2025 |
| Robert Joseph Cobuzzi Jr | Chief Operating Officer · Jan 7, 2020 – Feb 4, 2025 · Past |
| Sylvie Grégoire | Co-Founder · Since at least Jun 10, 2026 |
| William Elder | Chief Financial Officer and General Counsel · Since at least Sep 22, 2020 |